StockDuty ← Dashboard Oct 29, 2026 12:25 PM ET
SignalCorporate

Merck (MRK) Surpasses Q3 Earnings and Revenue Estimates

Merck beat Q3 earnings and revenue estimates.

What happened: Merck ($MRK) reported quarterly adjusted earnings of $2.49 per share and revenue of $18.09 billion, beating the Zacks Consensus Estimate for both. Key numbers: EPS $2.49 vs. estimate $2.12, a +17.45% surprise, versus $2.58 a year ago. Why it matters: Estimate revisions trend was unfavorable ahead of the release, translating into a Zacks Rank #5 (Strong Sell), and the shares are expected to underperform the market in the near future. The Large Cap Pharmaceuticals industry is in the bottom 11% of Zacks-ranked industries. Market: -0.6% today ($140.93), +33.4% YTD, 0.8x vol — as of 12:15 UTC Verified: Q3_2026 (Oct 29) revenue $17.3B vs $17.3B est; next print ~Jan 28 Coverage: 5 outlets in 24h
Merck ($MRK) reported quarterly adjusted earnings of $2.49 per share and revenue of $18.09 billion, beating the Zacks Consensus Estimate for both.
Estimate revisions trend was unfavorable ahead of the release, translating into a Zacks Rank #5 (Strong Sell), and the shares are expected to underperform the market in the near future. The Large Cap Pharmaceuticals industry is in the bottom 11% of Zacks-ranked industries. Market: -0.6% today ($140.93), +33.4% YTD, 0.8x vol — as of 12:15 UTC Verified: Q3_2026 (Oct 29) revenue $17.3B vs $17.3B est; next print ~Jan 28
Sources